Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
Medtronic
Express Scripts
Boehringer Ingelheim
Harvard Business School

Last Updated: December 14, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Volinanserin

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the drug development status for Volinanserin?

Volinanserin is an investigational drug.

There have been 4 clinical trials for Volinanserin. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2008.

The most common disease conditions in clinical trials are Sleep Initiation and Maintenance Disorders, Diabetes Mellitus, and Diabetes Mellitus, Type 2. The leading clinical trial sponsors are Sanofi and [disabled in preview].

Recent Clinical Trials for Volinanserin
TitleSponsorPhase
Comparison of Volinanserin and Lormetazepam in the Treatment of Insomnia Characterized by Sleep Maintenance DifficultiesSanofiPhase 3
Efficacy and Safety of M100907 on Sleep Maintenance Insomnia With a Sub-study in Stable Type II Diabetes MellitusSanofiPhase 3
Efficacy an Safety of Volinanserin on Sleep Maintenance Insomnia With a Sub-study on Stable Type II Diabetes MellitusSanofiPhase 3

See all Volinanserin clinical trials

Clinical Trial Summary for Volinanserin

Top disease conditions for Volinanserin
Top clinical trial sponsors for Volinanserin

See all Volinanserin clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Medtronic
Johnson and Johnson
McKinsey
AstraZeneca
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.